The Creating Hope Act of 2011 would encourage the creation of new drugs for underserved children who suffer from serious and rare medical conditions, including life-threatening cancers, by providing a voucher to pharmaceutical companies who develop such drugs. This voucher could be used to

Pediatric Cancer Each year around 13,500 children are diagnosed with cancer in the US, that’s more than a classroom of kids a day.

35,000 children are currently in treatment for cancer.

Some 25% of all kids who are diagnosed with cancer die.

Some pediatric brain tumors, such as brain stem gliomas and pontine gliomas, are terminal upon diagnosis and no new protocols have been developed in 30 years.

The Creating Hope Act of 2011 provides market incentives to pharmaceutical companies to develop drugs for pediatric rare diseases.